Effects of different metastasis patterns, surgery and other factors on the prognosis of patients with stage IV non‑small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) linked database analysis

Liao,Yi; Fan,Xianming; Wang,Xue

doi:10.3892/ol.2019.10373

Effects of different metastasis patterns, surgery and other factors on the prognosis of patients with stage IV non‑small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) linked database analysis

Authors:
- Yi Liao
- Xianming Fan
- Xue Wang
View Affiliations

Affiliations: Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China
Published online on: May 20, 2019 https://doi.org/10.3892/ol.2019.10373
Pages: 581-592
Copyright: © Liao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The surgical treatment of patients with advanced lung cancer remains controversial. The current study aimed to identify the factors affecting the prognosis of patients with stage IV non‑small cell lung cancer (NSCLC) and to clarify the surgery guidelines. A total of 27,725 patients diagnosed with stage IV NSCLC were selected from the Surveillance, Epidemiology, and End Results program between 2010 and 2013. The sex, age, ethnicity, marital status, Tumor‑Node‑Metastasis stage, radiation therapy received and surgical status of each patient were recorded. Patients were followed up to November 2015. Survival rates were estimated by the Kaplan‑Meier method. Single‑ and multi‑factor analyses were performed using the log‑rank test and multivariate Cox regression analysis respectively. In the isolated organ metastasis cohort, patients with liver metastasis alone had the worst prognosis, with a median overall survival (OS) of 4 months (liver metastasis vs. other organ metastases; P<0.001). Patients with lung metastasis only had the best prognosis, with a median OS of 8 months (lung metastasis vs. other organ metastases; P<0.001). Furthermore, patients with only one metastasis had the best prognosis, with a median OS of 6 months (single metastasis vs. multiple‑organ metastases; P<0.001). The multivariate Cox regression analysis of the isolated‑organ metastasis cohort and the multiple‑organ metastases cohort revealed that patients who were ≤60 years, female, married, Asian, with N0 stage, had only bone metastasis, accepted wedge resection or lobectomy of the primary tumor, had surgical procedure to distant lymph node(s), and received beam radiation had an improved prognosis compared with the other patients. Age, sex, tumor type, ethnicity, N stage, number and type of metastatic lesions, surgical treatment of primary and metastatic lesions and radiation therapy are factors which influence the prognosis of patients with stage IV NSCLC. Furthermore, surgery may still benefit these patients.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
3	Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, et al: SEER Cancer Statistics Review, 1975–2015, National Cancer Institute. Bethesda, MD: 2018, https://seer.cancer.gov/archive/csr/1975_2015/September 10–2018
4	Duan L, Pang HL, Chen WJ, Shen WW, Cao PP, Wang SM, Liu LL and Zhang HL: The role of GDF15 in bone metastasis of lung adenocarcinoma cells. Oncol Rep. 41:2379–2388. 2019.PubMed/NCBI
5	Riihimäki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J and Hemminki K: Metastatic sites and survival in lung cancer. Lung Cancer. 86:78–84. 2014. View Article : Google Scholar : PubMed/NCBI
6	Wang Y, Xie S and He B: Effect of EGFR gene polymorphism on efficacy of chemotherapy combined with targeted therapy for non-small cell lung cancer in Chinese patients. Am J Cancer Res. 9:619–627. 2019.PubMed/NCBI
7	Sosa Iglesias V, Giuranno L, Dubois LJ, Theys J and Vooijs M: Drug resistance in non-small cell lung cancer: A potential for NOTCH Targeting? Front Oncol. 8:2672018. View Article : Google Scholar : PubMed/NCBI
8	Kogure Y: Cost effectiveness and health economics of immune checkpoint inhibitors for non-small cell lung cancer. Gan To Kagaku Ryoho. 45:781–784. 2018.(In Japanese). PubMed/NCBI
9	Skinner KE, Fernandes AW, Walker MS Pavilack M and VanderWalde A: Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: A real-world observational study. J Med Econ. 21:192–200. 2018. View Article : Google Scholar : PubMed/NCBI
10	Furák J, Troján I, Szöke T, Agócs L, Csekeö A, Kas J, Svastics E, Eller J and Tiszlavicz L: Lung cancer and its operable brain metastasis: Survival rate and staging problems. Ann Thorac Surg. 79:241–247. 2005. View Article : Google Scholar : PubMed/NCBI
11	Hanagiri T, Takenaka M, Oka S, Shigematsu Y, Nagata Y, Shimokawa H, Uramoto H and Tanaka F: Results of a surgical resection for patients with stage IV non-small-cell lung cancer. Clin Lung Cancer. 13:220–224. 2012. View Article : Google Scholar : PubMed/NCBI
12	Congedo MT, Cesario A, Lococo F, De Waure C, Apolone G, Meacci E, Cavuto S and Granone P: Surgery for oligometastatic non-small cell lung cancer: Long-term results from a single center experience. J Thorac Cardiovasc Surg. 144:444–452. 2012. View Article : Google Scholar : PubMed/NCBI
13	Tieqin L, Hongxu L, Yu L, Shun X and Chunlu Y: Influencing factors of survival rate on 44 cases of postoperative stage IV non-small-celllung cancer. Chin J Ciinicians (Eiectronic Ed). 7:605–608. 2013.
14	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. (7th). Springer. (New York, NY). 2009.
15	Delea T, Langer C, McKiernan J, Liss M, Edelsberg J, Brandman J, Sung J, Raut M and Oster G: The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology. 67:390–396. 2004. View Article : Google Scholar : PubMed/NCBI
16	Hofferberth SC, Grinstaff MW and Colson YL: Nanotechnology applications in thoracic surgery. Eur J Cardiothorac Surg. 50:6–16. 2016. View Article : Google Scholar : PubMed/NCBI
17	Vaughn C, Mychaskiw G II and Sewell P: Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. Anesth Analg. 94:1149–1151. 2002. View Article : Google Scholar : PubMed/NCBI
18	Tutar N, Yurci A, Güneş I, Gülmez İ, Gürsoy Ş, Önal Ö and Canöz Ö: The role of endobronchial and endoscopic ultrasound guided fine needle aspiration for mediastinal nodal staging of non-small-cell lung cancer. Tuberk Toraks. 66:85–92. 2018. View Article : Google Scholar : PubMed/NCBI
19	Reck M and Rabe KF: Precision diagnosis and treatment for advanced non-small-cell lung cancer. N Engl J Med. 377:849–861. 2017. View Article : Google Scholar : PubMed/NCBI
20	Dong F, Shen Y, Gao F, Xu T, Wang X, Zhang X, Zhong S, Zhang M, Chen S and Shen Z: Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: A population-based study. Cancer Manag Res. 9:611–626. 2017. View Article : Google Scholar : PubMed/NCBI
21	Luo D, Liu Q, Yu W, Ma Y, Zhu J, Lian P, Cai S, Li Q and Li X: Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: A population-based study. Int J Colorectal Dis. 33:1241–1249. 2018. View Article : Google Scholar : PubMed/NCBI
22	Tamura T, Kurishima K, Nakazawa K, Kagohashi K, Ishikawa H, Satoh H and Hizawa N: Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol. 3:217–221. 2015. View Article : Google Scholar : PubMed/NCBI
23	Nakazawa K, Kurishima K, Tamura T, Kagohashi K, Ishikawa H, Satoh H and Hizawa N: Specific organ metastases and survival in small cell lung cancer. Oncol Lett. 4:617–620. 2012. View Article : Google Scholar : PubMed/NCBI
24	Yang J, Zhang Y, Sun X, Gusdon AM, Song N, Chen L, Jiang G and Huang Y: The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: A SEER-based study. J Cancer Res Clin Oncol. 144:1835–1842. 2018. View Article : Google Scholar : PubMed/NCBI
25	Gibson AJW, Li H, D'Silva A, Tudor RA, Elegbede AA, Otsuka SM, Bebb DG and Cheung WY: Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer. Med Oncol. 35:1172018. View Article : Google Scholar : PubMed/NCBI
26	Rami-Porta R, Bolejack V, Crowley J, Ball D, Kim J, Lyons G, Rice T, Suzuki K, Thomas CF Jr, Travis WD, et al: The IASLC lung cancer staging project: Proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 10:990–1003. 2015. View Article : Google Scholar : PubMed/NCBI
27	Oweira H, Petrausch U, Helbling D, Schmidt J, Mannhart M, Mehrabi A, Schöb O, Giryes A, Decker M and Abdel-Rahman O: Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis. World J Gastroenterol. 23:1872–1880. 2017. View Article : Google Scholar : PubMed/NCBI
28	Hidalgo M: Pancreatic cancer. N Engl J Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
29	Shi Y, Sun Y, Yu J, Ding C, Wang Z, Wang C, Wang D, Wang C, Wang Z, Wang M, et al: China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version). Asia Pac J Clin Oncol. 13:87–103. 2017. View Article : Google Scholar : PubMed/NCBI
30	Shi Y, Sun Y, Yu J, Ding C, Ma Z, Wang Z, Wang D, Wang Z, Wang M, Wang Y, et al: China experts consensus on the diagnosis and treatment of brain metastases of lung cancer (2017 version). Zhongguo Fei Ai Za Zhi. 20:1–13. 2017.(In Chinese). PubMed/NCBI
31	Sun Y, Guan Z, Liao M, Yu X, Wang C, Wang J, Niu X, Shi Y, Zhi X, Liu Y, et al: Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2014 version). Zhongguo Fei Ai Za Zhi. 17:57–72. 2014.(In Chinese). PubMed/NCBI
32	Schmelzle M, Eisenberger CF, Am Esch JS II, Matthaei H, Krausch M and Knoefel WT: Non-colorectal, non-neuroendocrine, and non-sarcoma metastases of the liver: Resection as a promising tool in the palliative management. Langenbecks Arch Surg. 395:227–234. 2010. View Article : Google Scholar : PubMed/NCBI
33	Ileana E, Greillier L, Moutardier V and Barlesi F: Surgical resection of liver non-small cell lung cancer metastasis: A dual weapon? Lung Cancer. 70:221–222. 2010. View Article : Google Scholar : PubMed/NCBI
34	Di Carlo I, Grasso G, Patane' D, Russello D and Latteri F: Liver metastases from lung cancer: Is surgical resection justified? Ann Thorac Surg. 76:291–293. 2003. View Article : Google Scholar : PubMed/NCBI
35	Reddy SK, Barbas AS, Marroquin CE, Morse MA, Kuo PC and Clary BM: Resection of noncolorectal nonneuroendocrine liver metastases: A comparative analysis. J Am Coll Surg. 204:372–382. 2007. View Article : Google Scholar : PubMed/NCBI
36	Abdel-Rahman O: Outcomes of surgery as part of the management of metastatic Non-small-cell lung cancer: A Surveillance, epidemiology and End results database analysis. Cancer Invest. 36:238–245. 2018. View Article : Google Scholar : PubMed/NCBI
37	Liu K, Zheng D, Xu G, Du Z and Wu S: Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End results database analysis. PLoS One. 12:e01873502017. View Article : Google Scholar : PubMed/NCBI
38	Setzer M, Robinson LA and Vrionis FD: Management of locally advanced pancoast (superior sulcus) tumors with spine involvement. Cancer Control. 21:158–167. 2014. View Article : Google Scholar : PubMed/NCBI
39	Rui M, Pengqing Y and Chang C: Progress in resection and reconstruction of chest wall in non-small lung cancer. Chin J Clin Thorac Cardiovasc Surg. 22:685–690. 2015.
40	Dai C, Shen J, Ren Y, Zhong S, Zheng H, He J, Xie D, Fei K, Liang W, Jiang G, et al: Choice of surgical procedure for patients with Non-small-cell lung cancer ≤1 cm or >1 to 2 cm among lobectomy, segmentectomy, and wedge resection: A population-based study. J Clin Oncol. 34:3175–3182. 2016. View Article : Google Scholar : PubMed/NCBI
41	Ludwig MS, Goodman M, Miller DL and Johnstone PA: Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest. 128:1545–1550. 2005. View Article : Google Scholar : PubMed/NCBI
42	Zhang R, Li P, Li Q, Qiao Y, Xu T, Ruan P, Song Q and Fu Z: Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database. Cancer Med. 7:5015–5026. 2018. View Article : Google Scholar : PubMed/NCBI
43	Herskovic A, Chitti B, Christos P, Wernicke AG and Parashar B: Addition of surgery after radiation significantly improves survival in stage IIIB Non-small cell lung cancer: A population-based analysis. World J Surg. 41:758–762. 2017. View Article : Google Scholar : PubMed/NCBI
44	Verma V, Rwigema JM, Adeberg S and Simone CB II: Enrollment of elderly patients with locally advanced non-small cell lung cancer in multi-institutional trials of proton beam radiation therapy. Clin Lung Cancer. 18:441–443. 2017. View Article : Google Scholar : PubMed/NCBI
45	He M, Li S, Chen Y, Ouyang M, Chen P and Zhang J: 131I-chTNT injection to relieve tracheal obstruction in advanced NSCLC patient. Technol Health Care. 24 (Suppl 2):S513–S519. 2016. View Article : Google Scholar : PubMed/NCBI
46	Hendriks LE, Hermans BC, van den Beuken-van Everdingen MH, Hochstenbag MM and Dingemans AM: Effect of Bisphosphonates, Denosumab, and radioisotopes on bone pain and quality of life in patients with non-small cell lung cancer and bone metastases: A systematic review. J Thorac Oncol. 11:155–173. 2016. View Article : Google Scholar : PubMed/NCBI
47	Toffart AC, Duruisseaux M, Brichon PY, Pirvu A, Villa J, Selek L, Guillem P, Dumas I, Ferrer L, Levra MG and Moro-Sibilot D: Operation and chemotherapy: Prognostic factors for lung cancer with one synchronous metastasis. Ann Thorac Surg. 105:957–965. 2018. View Article : Google Scholar : PubMed/NCBI
48	Cheng TD, Darke AK, Redman MW, Zirpoli GR, Davis W, Payne Ondracek R, Bshara W, Omilian AR, Kratzke R, Reid ME, et al: Smoking, Sex, and Non-small cell lung cancer: Steroid hormone receptors in tumor tissue (S0424). J Natl Cancer Inst. 110:734–742. 2018. View Article : Google Scholar : PubMed/NCBI
49	Merrill RM and Johnson E: Benefits of marriage on relative and conditional relative cancer survival differ between males and females in the USA. J Cancer Surviv. 11:578–589. 2017. View Article : Google Scholar : PubMed/NCBI
50	Wu Y, Ai Z and Xu G: Marital status and survival in patients with non-small cell lung cancer: An analysis of 70006 patients in the SEER database. Oncotarget. 8:103518–103534. 2017.PubMed/NCBI
51	Richards TB, Henley SJ, Puckett MC, Weir HK, Huang B, Tucker TC and Allemani C: Lung cancer survival in the United States by race and stage (2001–2009): Findings from the CONCORD-2 study. Cancer. 123:5079–5099. 2017. View Article : Google Scholar : PubMed/NCBI
52	Williams CD, Salama JK, Moghanaki D, Karas TZ and Kelley MJ: Impact of race on treatment and survival among U.S. Veterans with early-stage lung cancer. J Thorac Oncol. 11:1672–1681. 2016. View Article : Google Scholar : PubMed/NCBI
53	Videtic GM, Reddy CA, Chao ST, Rice TW, Adelstein DJ, Barnett GH, Mekhail TM, Vogelbaum MA and Suh JH: Gender, race, and survival: A study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification. Int J Radiat Oncol Biol Phys. 75:1141–1147. 2009. View Article : Google Scholar : PubMed/NCBI
54	Tannenbaum SL, Koru-Sengul T, Zhao W, Miao F and Byrne MM: Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status. Cancer J. 20:237–245. 2014. View Article : Google Scholar : PubMed/NCBI
55	Yoshinaga Y, Enatsu S, Iwasaki A and Shirakusa T: Surgical treatment for primary non-small cell lung cancer with synchronous brain metastases. Kyobu Geka. 59:41–45. 2016.(In Japanese).
56	Ramalingam S, Dinan MA and Crawford J: Survival comparison in patients with Stage IV lung cancer in Academic versus Community centers in the United States. J Thorac Oncol. 13:1842–1850. 2018. View Article : Google Scholar : PubMed/NCBI
57	Xiaolan J and Jia W: Prognostic factors for bone metastasis of patients with non-small-cell lung cancer. Shandong Med. 56:88–90. 2016.
58	Masters GA, Temin S, Azzoli CG, Giaccone G, Baker S Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller JH, et al: Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 33:3488–3515. 2015. View Article : Google Scholar : PubMed/NCBI
59	Zhang YL, Yuan JQ, Wang KF, Fu XH, Han XR, Threapleton D, Yang ZY, Mao C and Tang JL: The prevalence of EGFR mutation in patients with non-small cell lung cancer: A systematic review and meta-analysis. Oncotarget. 7:78985–78993. 2016.PubMed/NCBI